15-41567406-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006293.4(TYRO3):c.830C>T(p.Pro277Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000357 in 1,606,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 0 hom. )
Consequence
TYRO3
NM_006293.4 missense
NM_006293.4 missense
Scores
2
17
Clinical Significance
Conservation
PhyloP100: 4.92
Genes affected
TYRO3 (HGNC:12446): (TYRO3 protein tyrosine kinase) The gene is part of a 3-member transmembrane receptor kinase receptor family with a processed pseudogene distal on chromosome 15. The encoded protein is activated by the products of the growth arrest-specific gene 6 and protein S genes and is involved in controlling cell survival and proliferation, spermatogenesis, immunoregulation and phagocytosis. The encoded protein has also been identified as a cell entry factor for Ebola and Marburg viruses. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.030841798).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYRO3 | NM_006293.4 | c.830C>T | p.Pro277Leu | missense_variant | 7/19 | ENST00000263798.8 | NP_006284.2 | |
TYRO3 | NM_001330264.2 | c.695C>T | p.Pro232Leu | missense_variant | 7/19 | NP_001317193.1 | ||
TYRO3 | XM_017022543.3 | c.830C>T | p.Pro277Leu | missense_variant | 7/19 | XP_016878032.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYRO3 | ENST00000263798.8 | c.830C>T | p.Pro277Leu | missense_variant | 7/19 | 1 | NM_006293.4 | ENSP00000263798 | A2 | |
TYRO3 | ENST00000559066.5 | c.695C>T | p.Pro232Leu | missense_variant | 7/19 | 5 | ENSP00000454050 | P4 | ||
TYRO3 | ENST00000560227.1 | n.405C>T | non_coding_transcript_exon_variant | 2/3 | 5 | |||||
TYRO3 | ENST00000559815.1 | c.29C>T | p.Pro10Leu | missense_variant, NMD_transcript_variant | 1/4 | 5 | ENSP00000453835 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152234Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
58
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000333 AC: 81AN: 243562Hom.: 0 AF XY: 0.000334 AC XY: 44AN XY: 131654
GnomAD3 exomes
AF:
AC:
81
AN:
243562
Hom.:
AF XY:
AC XY:
44
AN XY:
131654
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000354 AC: 515AN: 1453690Hom.: 0 Cov.: 32 AF XY: 0.000371 AC XY: 268AN XY: 723022
GnomAD4 exome
AF:
AC:
515
AN:
1453690
Hom.:
Cov.:
32
AF XY:
AC XY:
268
AN XY:
723022
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000381 AC: 58AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74496
GnomAD4 genome
AF:
AC:
58
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
33
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
7
ExAC
AF:
AC:
36
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.830C>T (p.P277L) alteration is located in exon 7 (coding exon 7) of the TYRO3 gene. This alteration results from a C to T substitution at nucleotide position 830, causing the proline (P) at amino acid position 277 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.0010
.;B
Vest4
MVP
MPC
0.41
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at